Stock Expert AI
EHOS company logo

EHOS: AI 评分 51/100 — AI 分析 (4月 2026)

Ehouse Global, Inc. focuses on developing, producing, and selling liquid supplements, including vitamins, minerals, and sports nutrition products. The company operates in the competitive healthcare and biotechnology sectors.

Key Facts: AI Score: 51/100 Sector: Healthcare

公司概况

概要:

Ehouse Global, Inc. focuses on developing, producing, and selling liquid supplements, including vitamins, minerals, and sports nutrition products. The company operates in the competitive healthcare and biotechnology sectors.
Ehouse Global, Inc., founded in 2003, develops and distributes liquid supplements, including vitamins, minerals, and sports nutrition products. Operating within the biotechnology sector, the company caters to the diet and wellness market, facing competition from established players and evolving consumer preferences.

EHOS是做什么的?

Ehouse Global, Inc., established in 2003 by Scott Corlett and Edward J. Peplinski, is a biotechnology company focused on the development, production, and sale of liquid supplements. Headquartered in San Diego, California, the company offers a range of products, including vitamins, minerals, sports nutrition supplements, and diet and wellness products. These supplements are designed to cater to health-conscious consumers seeking convenient and effective ways to enhance their nutritional intake. Since its inception, Ehouse Global has aimed to provide accessible and innovative health solutions through its liquid supplement formulations. The company's products are marketed towards individuals interested in improving their overall health, athletic performance, or managing specific dietary needs. The liquid format allows for easy consumption and potentially faster absorption compared to traditional pill or capsule forms. Ehouse Global operates in a competitive market, facing competition from both large, established supplement manufacturers and smaller, niche brands. The company's success depends on its ability to differentiate its products through unique formulations, effective marketing, and strong distribution channels. As of 2026, the company is managed by Jonathan Smith and employs a small team of two individuals.

EHOS的投资论点是什么?

Ehouse Global, Inc. presents a speculative investment opportunity within the biotechnology and supplement industry. With a market capitalization of $0.00B and a negative P/E ratio, the company's financial performance requires careful scrutiny. Potential the may be worth researching company's limited operating scale, reflected in its small employee base of two, and the competitive landscape of the supplement market. Growth catalysts may include successful product innovation and expansion into new distribution channels. However, the company's OTC listing and negative beta of -7.57 indicate higher risk and volatility. A thorough due diligence process is essential to assess the company's long-term viability and growth potential.

EHOS在哪个行业运营?

Ehouse Global, Inc. operates within the global dietary supplements market, which is characterized by increasing consumer awareness of health and wellness. The market includes vitamins, minerals, herbal supplements, and sports nutrition products. Competition is intense, with major players like GBLX and smaller niche brands vying for market share. Ehouse Global's focus on liquid supplements positions it within a specific segment of this market, requiring effective differentiation and marketing strategies to capture consumer attention. The industry is also subject to regulatory scrutiny, requiring companies to comply with labeling and safety standards.
Biotechnology
Healthcare

EHOS有哪些增长机遇?

  • Expansion into new distribution channels: Ehouse Global can explore partnerships with major retailers, online marketplaces, and specialty health stores to increase product visibility and accessibility. The online supplement market is experiencing rapid growth, offering a significant opportunity for Ehouse Global to reach a wider customer base. A successful expansion into these channels could significantly boost sales and brand recognition by the end of 2027.
  • Product innovation and development: Investing in research and development to create new and innovative liquid supplement formulations can attract health-conscious consumers seeking unique and effective solutions. This includes exploring new ingredients, delivery methods, and targeted health benefits. Successful product launches could drive revenue growth and establish Ehouse Global as a leader in the liquid supplement market by 2028.
  • Targeted marketing campaigns: Implementing targeted marketing campaigns that focus on specific consumer segments, such as athletes, seniors, or individuals with dietary restrictions, can increase brand awareness and drive sales. These campaigns can leverage social media, influencer marketing, and content marketing to reach potential customers and educate them about the benefits of Ehouse Global's products. Effective campaigns could yield measurable results within 12-18 months.
  • Strategic partnerships: Collaborating with other companies in the health and wellness industry, such as fitness studios, nutritionists, or healthcare providers, can expand Ehouse Global's reach and credibility. These partnerships can involve cross-promotional activities, joint product development, or referral programs. Strategic alliances could provide access to new customer segments and enhance brand reputation by 2027.
  • International market expansion: Exploring opportunities to expand into international markets, particularly in regions with growing demand for dietary supplements, can significantly increase Ehouse Global's revenue potential. This requires careful consideration of local regulations, cultural preferences, and distribution channels. Successful international expansion could diversify revenue streams and reduce reliance on the domestic market by 2029.
  • Market capitalization of $0.00B, indicating a micro-cap company.
  • Negative P/E ratio of -0.00, suggesting the company is not currently profitable.
  • Beta of -7.57, indicating a high degree of volatility and inverse correlation to the market.
  • Focus on liquid supplements, a niche market within the broader supplement industry.
  • Small employee base of 2, reflecting a limited operational scale.

EHOS提供哪些产品和服务?

  • Develops liquid supplements containing vitamins and minerals.
  • Produces sports nutrition supplements in liquid form.
  • Offers diet and wellness products designed for health-conscious consumers.
  • Formulates liquid supplements for easy consumption and absorption.
  • Markets its products to individuals seeking to improve their overall health and wellness.
  • Distributes its supplements through various channels, including online and retail.

EHOS如何赚钱?

  • Develops and manufactures liquid supplements.
  • Sells products directly to consumers through online channels.
  • Partners with retailers and distributors to expand market reach.
  • Health-conscious individuals seeking convenient supplement options.
  • Athletes and fitness enthusiasts looking for performance-enhancing products.
  • Individuals with dietary restrictions or specific nutritional needs.
  • Consumers seeking to improve their overall health and wellness.
  • Proprietary liquid supplement formulations.
  • Established brand reputation within the niche market.
  • Strong relationships with key retailers and distributors.
  • Focus on innovation and product development.

什么因素可能推动EHOS股价上涨?

  • Upcoming: Potential product launches of new liquid supplement formulations in Q4 2026.
  • Ongoing: Expansion of online sales channels through partnerships with e-commerce platforms.
  • Ongoing: Marketing campaigns targeting specific consumer segments to increase brand awareness.

EHOS的主要风险是什么?

  • Potential: Intense competition from established supplement manufacturers could erode market share.
  • Potential: Changing consumer preferences and trends may impact demand for liquid supplements.
  • Potential: Regulatory scrutiny and compliance requirements could increase operating costs.
  • Ongoing: Limited financial resources may hinder growth initiatives.
  • Ongoing: OTC listing increases risk due to limited disclosure and liquidity.

EHOS的核心优势是什么?

  • Focus on liquid supplements, a niche market.
  • Established brand reputation.
  • Proprietary formulations.
  • Experienced leadership.

EHOS的劣势是什么?

  • Small employee base and limited resources.
  • Dependence on a limited product line.
  • Limited brand awareness compared to larger competitors.
  • OTC listing indicates higher risk.

EHOS有哪些机遇?

  • Expansion into new distribution channels.
  • Product innovation and development.
  • Strategic partnerships with complementary businesses.
  • International market expansion.

EHOS面临哪些威胁?

  • Intense competition from established supplement manufacturers.
  • Changing consumer preferences and trends.
  • Regulatory scrutiny and compliance requirements.
  • Economic downturn affecting consumer spending.

EHOS的竞争对手是谁?

  • Bella Bridge Brands, Inc. — Focuses on broader health and wellness products. — (BBBT)
  • Brandix Ltd. — International competitor with diverse product lines. — (BRAXF)
  • Global Technologies Acquisition I Corp. — Operates in the broader technology and healthcare space. — (GBLX)
  • Gastech Solutions, Inc. — Focuses on gas technology solutions. — (GSTC)
  • Harte Hanks Data Services — Provides data-driven marketing solutions. — (HTDS)

Key Metrics

  • MoonshotScore: 51/100

Company Profile

  • CEO: Jonathan Smith
  • Headquarters: San Diego, US
  • Employees: 2
  • Founded: 2013

AI Insight

AI analysis pending for EHOS
  • OTC Tier: OTC Other
  • Disclosure Status: Unknown

常见问题

What does Ehouse Global, Inc. do?

Ehouse Global, Inc. is a biotechnology company that develops, produces, and sells liquid supplements. Its product line includes vitamins, minerals, sports nutrition supplements, and diet and wellness products. These supplements are designed to cater to health-conscious consumers seeking convenient and effective ways to enhance their nutritional intake. The company operates primarily in the online and retail channels, targeting individuals interested in improving their overall health and athletic performance.

What do analysts say about EHOS stock?

As of March 17, 2026, there is no available analyst coverage for Ehouse Global, Inc. due to its OTC listing and small market capitalization. Key valuation metrics such as price targets and earnings estimates are not available. Investors should conduct their own independent research and due diligence before making any investment decisions. The company's growth potential and financial performance require careful evaluation, considering its competitive landscape and limited resources.

What are the main risks for EHOS?

Ehouse Global, Inc. faces several risks, including intense competition from established supplement manufacturers, changing consumer preferences, and regulatory scrutiny. The company's small size and limited resources may hinder its ability to compete effectively and adapt to market changes. Furthermore, its OTC listing increases risk due to limited disclosure and liquidity. Investors should carefully consider these risks before investing in EHOS.

热门股票

查看全部股票 →